![Raman Singh](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Raman Singh
Directeur/Bestuurslid bij LIQUIDIA CORPORATION
Vermogen: - $ op 31-05-2024
Profiel
Raman Singh is currently the Chief Executive Officer at Juniper Biologics Pte Ltd., the Independent Director at Liquidia Technologies, Inc., and the Independent Director at Liquidia Corp.
Previously, he served as the Chief Executive Officer at Mundipharma Pte Ltd.
from 2011 to 2020.
He also held positions as the Regional Director at Abbott Laboratories NZ Ltd.
and Abbott Australia Pty Ltd.
from 2007 to 2008, the Vice President-Commercial Operations at GSK Plc from 2008 to 2011, and the General Manager at Abbott Korea Ltd.
from 2005 to 2007.
Mr. Singh obtained a graduate degree from Thunderbird School of Global Management, an undergraduate degree from Osmania University in 1992, and an MBA from Assumption University.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
LIQUIDIA CORPORATION
-.--% | 26-04-2024 | 0 ( -.--% ) | - $ | 31-05-2024 |
Actieve functies van Raman Singh
Bedrijven | Functie | Begin |
---|---|---|
LIQUIDIA CORPORATION | Directeur/Bestuurslid | 28-06-2020 |
Liquidia Technologies, Inc.
![]() Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | Directeur/Bestuurslid | 01-12-2020 |
Juniper Biologics Pte Ltd.
![]() Juniper Biologics Pte Ltd. Miscellaneous Commercial ServicesCommercial Services Juniper Biologics Pte Ltd is a science-led pharmaceutical company based in Singapore, Singapore. Juniper Biologics is backed by the Sylvan Group and is focused on delivering novel therapies to improve the health and quality of life of patients. The Singaporean company has a growing presence in oncology and oncology supportive care, rare/orphan diseases, and gene therapy. The company was founded with a vision to provide treatments for unmet medical needs in specialist therapy areas. Raman Singh has been the CEO of the company since 2020. | Algemeen Directeur | 01-12-2020 |
Eerdere bekende functies van Raman Singh
Bedrijven | Functie | Einde |
---|---|---|
Mundipharma Pte Ltd.
![]() Mundipharma Pte Ltd. Pharmaceuticals: MajorHealth Technology Mundipharma Pte Ltd. develops pharmaceutical products. Its therapy area includes analgesia, oncology, ophthalmology, respiratory, specialty care, and consumer healthcare. The company was founded in 2004 and is headquartered in Singapore. | Algemeen Directeur | 01-12-2020 |
GSK PLC | Corporate Officer/Principal | 01-01-2011 |
Abbott Australia Pty Ltd. | Corporate Officer/Principal | 01-01-2008 |
Abbott Laboratories NZ Ltd. | Corporate Officer/Principal | 01-01-2008 |
Abbott Korea Ltd.
![]() Abbott Korea Ltd. Medical DistributorsDistribution Services Abbott Korea Ltd. engages in the distribution of medical equipment, reagents, medicines, nutritional products, infant formula and baby foods. The company was founded on May 24, 1988 and is headquartered in Seoul, South Korea. | Corporate Officer/Principal | 01-01-2007 |
Opleiding van Raman Singh
Thunderbird School of Global Management | Graduate Degree |
Osmania University | Undergraduate Degree |
Assumption University | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
GSK PLC | Health Technology |
LIQUIDIA CORPORATION | Health Technology |
Bedrijven in privébezit | 6 |
---|---|
Liquidia Technologies, Inc.
![]() Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | Health Technology |
Abbott Korea Ltd.
![]() Abbott Korea Ltd. Medical DistributorsDistribution Services Abbott Korea Ltd. engages in the distribution of medical equipment, reagents, medicines, nutritional products, infant formula and baby foods. The company was founded on May 24, 1988 and is headquartered in Seoul, South Korea. | Distribution Services |
Abbott Laboratories NZ Ltd. | |
Mundipharma Pte Ltd.
![]() Mundipharma Pte Ltd. Pharmaceuticals: MajorHealth Technology Mundipharma Pte Ltd. develops pharmaceutical products. Its therapy area includes analgesia, oncology, ophthalmology, respiratory, specialty care, and consumer healthcare. The company was founded in 2004 and is headquartered in Singapore. | Health Technology |
Abbott Australia Pty Ltd. | |
Juniper Biologics Pte Ltd.
![]() Juniper Biologics Pte Ltd. Miscellaneous Commercial ServicesCommercial Services Juniper Biologics Pte Ltd is a science-led pharmaceutical company based in Singapore, Singapore. Juniper Biologics is backed by the Sylvan Group and is focused on delivering novel therapies to improve the health and quality of life of patients. The Singaporean company has a growing presence in oncology and oncology supportive care, rare/orphan diseases, and gene therapy. The company was founded with a vision to provide treatments for unmet medical needs in specialist therapy areas. Raman Singh has been the CEO of the company since 2020. | Commercial Services |